Abstract Purpose of Review The purpose of this narrative review and update is to summarize
the current knowledge and provide recent advances on the neurologic complications of …

Summary Introduction Intracranial infectious aneurysms (IIAs), or mycotic aneurysms are
rare, representing between 0.7% and 5.4% of all intracranial aneurysms. To clarify the safety …

The authors retrospectively reviewed their cases of infectious intracranial aneurysms and
discuss results and trends of current treatment modalities including medical, neurosurgical …

Background: Pseudoaneurysms (PSAs) of the internal carotid artery (ICA) are uncommon
lesions. Various surgical and endovascular options are available for the management of …

Introduction With rising rates of intravenous drug use, Infectious Intracranial aneurysms
(IIAs) are a relevant topic for investigation. We performed a systematic review to better …

Abstract Introduction Infectious intracranial aneurysms (IIAs) account for approximately 15%
of all pediatric intracranial aneurysms. Histologically, they are pseudoaneurysms that …

The United States is in the midst of an opioid use epidemic, which has severe medical,
social, and economic consequences. Addictions to and abuse of prescription and illicit …

Purpose Endovascular treatment (EVT) has become a major option in management of
infectious intracranial aneurysms (IIAs) complicating infective endocarditis. We report a …

Objective A review of endovascular cerebral mycotic aneurysm treatment with Onyx liquid
embolic, N-butyl-2-cyanoacrylate (NBCA), or coil embolization has not been reported. The …

Abstract Objective: Intracranial infectious aneurysms (IIAs) are a rare clinical entity without a
definitive treatment guideline. In this study, we evaluate the treatment options of these …